云顶新耀完成 3.1 亿美元 C 轮融资，高瓴资本、建峖实业等机构共同领投

云顶新耀完成 3.1 亿美元 C 轮融资，高瓴资本、建峖实业等机构共同领投
云顶新耀宣布完成 3.1 亿美元 C 轮融资，本轮 3.1 亿美元的融资包括两部分优先股筹资，2.6
亿美元 C-2 轮以及 5000 万美元 C-1 轮 … C-2 轮融资由建峖实业投资（Janchor Partners）
领投，RA Capital Management 和高瓴资本（Hillhouse Capital）共同领投 … 云顶新耀总裁兼
首席财务官何颖表示： 我们很高兴能与这些杰出的全球领先生物制药机构投资者合作，并期待
在云顶新耀令人兴奋和重要的增长时期与他们合作。
Genting Xinyao completes $310 million C round of financing, co-led by Gaoqi Capital, Jianyi Industrial and other institutions
Genting Xinyao announces completion of $310 million C round of financing, $310 million in current financing including two-part preferred stock financing, 2.6
$100 million C-2 round and $50 million C-1 round … C-2 round of financing by Janchor Partners
Lead Investment, RA Capital Management and Hillhouse Capital Co-Lead … President and President of Genting Xinyao
“We are pleased to work with these outstanding global leading biopharmaceutical institutional investors and look forward to
Work with Genting during exciting and important growth periods.